Clean Ebitda vs Cost Of Revenue Analysis

CLEAN Stock

1,290 9.20 0.72%

Clean Science financial indicator trend analysis is way more than just evaluating Clean Science prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clean Science is a good investment. Please check the relationship between Clean Science Ebitda and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clean Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clean Science Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Clean Science's Ebitda and Cost Of Revenue is 0.8. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Clean Science and, assuming nothing else is changed. The correlation between historical values of Clean Science's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Clean Science and are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Clean Science's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.8

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Clean Science income statement and represents the costs associated with goods and services Clean Science provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Clean Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clean Science current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clean Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 27th of February 2025, Selling General Administrative is likely to grow to about 588.7 M, while Tax Provision is likely to drop about 751.1 M.

	2022	2023	2024	2025 (projected)
Gross Profit	6.1B	4.3B	4.9B	3.8B
Total Revenue	9.4B	7.8B	9.0B	6.2B

Gross Profit Total Revenue

Clean Science fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.52	0.92	0.98	0.92	0.96	0.97	0.89	0.41	0.36	0.92	0.97	-0.36	0.89	0.1	0.81	0.96	0.98	0.59	0.38	0.99	0.99	0.85	0.47	0.99	0.99
Short Long Term Debt Total	0.52		0.43	0.47	0.52	0.43	0.45	0.52	-0.07	0.76	0.52	0.37	-0.73	0.52	0.31	0.28	0.47	0.49	0.39	0.16	0.52	0.5	0.53	0.65	0.48	0.5
Other Current Liab	0.92	0.43		0.93	0.84	0.88	0.88	0.83	0.16	0.5	0.84	0.89	-0.52	0.83	-0.23	0.89	0.9	0.88	0.58	0.34	0.92	0.88	0.72	0.5	0.93	0.9
Total Current Liabilities	0.98	0.47	0.93		0.9	0.95	0.97	0.87	0.41	0.3	0.9	0.99	-0.3	0.87	0.01	0.86	0.96	0.98	0.58	0.41	0.95	0.96	0.83	0.56	1.0	0.98
Total Stockholder Equity	0.92	0.52	0.84	0.9		0.86	0.86	0.99	0.32	0.41	1.0	0.89	-0.38	0.99	0.16	0.74	0.89	0.91	0.71	0.28	0.91	0.91	0.96	0.49	0.91	0.91
Other Liab	0.96	0.43	0.88	0.95	0.86		0.98	0.81	0.54	0.26	0.86	0.96	-0.27	0.81	-0.05	0.89	0.97	0.97	0.51	0.54	0.95	0.95	0.76	0.56	0.95	0.98
Net Tangible Assets	0.97	0.45	0.88	0.97	0.86	0.98		0.8	0.57	0.25	0.86	0.97	-0.25	0.81	-0.01	0.88	0.99	0.99	0.47	0.57	0.94	0.95	0.76	0.56	0.97	0.99
Property Plant And Equipment Net	0.89	0.52	0.83	0.87	0.99	0.81	0.8		0.21	0.43	0.99	0.86	-0.4	1.0	0.21	0.68	0.84	0.87	0.76	0.15	0.89	0.88	0.98	0.43	0.88	0.87
Current Deferred Revenue	0.41	-0.07	0.16	0.41	0.32	0.54	0.57	0.21		-0.42	0.32	0.49	0.43	0.21	0.09	0.43	0.55	0.52	-0.1	0.76	0.33	0.43	0.22	0.2	0.4	0.51
Net Debt	0.36	0.76	0.5	0.3	0.41	0.26	0.25	0.43	-0.42		0.41	0.17	-1.0	0.43	-0.18	0.35	0.33	0.27	0.33	0.08	0.39	0.3	0.32	0.44	0.31	0.31
Retained Earnings	0.92	0.52	0.84	0.9	1.0	0.86	0.86	0.99	0.32	0.41		0.89	-0.38	0.99	0.16	0.74	0.89	0.91	0.71	0.28	0.91	0.91	0.96	0.49	0.91	0.91
Accounts Payable	0.97	0.37	0.89	0.99	0.89	0.96	0.97	0.86	0.49	0.17	0.89		-0.17	0.86	0.07	0.83	0.95	0.99	0.56	0.4	0.95	0.97	0.83	0.47	0.99	0.98
Cash	-0.36	-0.73	-0.52	-0.3	-0.38	-0.27	-0.25	-0.4	0.43	-1.0	-0.38	-0.17		-0.41	0.21	-0.36	-0.33	-0.26	-0.32	-0.07	-0.39	-0.3	-0.29	-0.41	-0.31	-0.31
Non Current Assets Total	0.89	0.52	0.83	0.87	0.99	0.81	0.81	1.0	0.21	0.43	0.99	0.86	-0.41		0.21	0.68	0.84	0.87	0.76	0.16	0.89	0.89	0.97	0.43	0.88	0.87
Non Currrent Assets Other	0.1	0.31	-0.23	0.01	0.16	-0.05	-0.01	0.21	0.09	-0.18	0.16	0.07	0.21	0.21		-0.46	-0.07	0.08	0.23	-0.41	0.11	0.18	0.39	-0.21	0.03	0.04
Other Assets	0.81	0.28	0.89	0.86	0.74	0.89	0.88	0.68	0.43	0.35	0.74	0.83	-0.36	0.68	-0.46		0.91	0.84	0.37	0.66	0.79	0.76	0.55	0.62	0.85	0.86
Cash And Short Term Investments	0.96	0.47	0.9	0.96	0.89	0.97	0.99	0.84	0.55	0.33	0.89	0.95	-0.33	0.84	-0.07	0.91		0.98	0.49	0.61	0.92	0.93	0.77	0.6	0.96	0.99
Net Receivables	0.98	0.49	0.88	0.98	0.91	0.97	0.99	0.87	0.52	0.27	0.91	0.99	-0.26	0.87	0.08	0.84	0.98		0.55	0.48	0.96	0.97	0.84	0.56	0.99	1.0
Common Stock Shares Outstanding	0.59	0.39	0.58	0.58	0.71	0.51	0.47	0.76	-0.1	0.33	0.71	0.56	-0.32	0.76	0.23	0.37	0.49	0.55		-0.17	0.62	0.59	0.76	0.24	0.59	0.54
Short Term Investments	0.38	0.16	0.34	0.41	0.28	0.54	0.57	0.15	0.76	0.08	0.28	0.4	-0.07	0.16	-0.41	0.66	0.61	0.48	-0.17		0.3	0.34	0.04	0.51	0.4	0.5
Non Current Liabilities Total	0.99	0.52	0.92	0.95	0.91	0.95	0.94	0.89	0.33	0.39	0.91	0.95	-0.39	0.89	0.11	0.79	0.92	0.96	0.62	0.3		0.99	0.86	0.44	0.97	0.96
Inventory	0.99	0.5	0.88	0.96	0.91	0.95	0.95	0.88	0.43	0.3	0.91	0.97	-0.3	0.89	0.18	0.76	0.93	0.97	0.59	0.34	0.99		0.86	0.4	0.97	0.97
Other Current Assets	0.85	0.53	0.72	0.83	0.96	0.76	0.76	0.98	0.22	0.32	0.96	0.83	-0.29	0.97	0.39	0.55	0.77	0.84	0.76	0.04	0.86	0.86		0.39	0.84	0.82
Other Stockholder Equity	0.47	0.65	0.5	0.56	0.49	0.56	0.56	0.43	0.2	0.44	0.49	0.47	-0.41	0.43	-0.21	0.62	0.6	0.56	0.24	0.51	0.44	0.4	0.39		0.55	0.55
Total Liab	0.99	0.48	0.93	1.0	0.91	0.95	0.97	0.88	0.4	0.31	0.91	0.99	-0.31	0.88	0.03	0.85	0.96	0.99	0.59	0.4	0.97	0.97	0.84	0.55		0.98
Total Current Assets	0.99	0.5	0.9	0.98	0.91	0.98	0.99	0.87	0.51	0.31	0.91	0.98	-0.31	0.87	0.04	0.86	0.99	1.0	0.54	0.5	0.96	0.97	0.82	0.55	0.98

Click cells to compare fundamentals

Clean Science Account Relationship Matchups

Clean Science fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	6.6B	9.2B	11.5B	14.0B	16.1B	8.1B
Other Current Liab	409.9M	221.8M	288.0M	448.0M	515.2M	279.1M
Total Current Liabilities	1.0B	1.3B	1.2B	1.6B	1.8B	1.1B
Total Stockholder Equity	5.4B	7.7B	10.1B	12.0B	13.8B	14.5B
Other Liab	141.8M	105.4M	179.4M	210.5M	242.1M	163.0M
Net Tangible Assets	2.7B	3.4B	5.4B	7.7B	8.8B	4.6B
Property Plant And Equipment Net	2.5B	3.4B	4.8B	7.0B	8.0B	8.4B
Current Deferred Revenue	10.4M	326.3M	267.3M	7.3M	8.4M	7.9M
Net Debt	(90.1M)	(575.7M)	(104.1M)	(84.2M)	(96.8M)	(101.6M)
Retained Earnings	5.2B	7.5B	9.9B	11.8B	13.6B	14.3B
Accounts Payable	609.9M	1.0B	805.1M	1.1B	1.2B	685.9M
Cash	93.4M	579.0M	124.7M	104.5M	94.0M	158.0M
Non Current Assets Total	2.6B	3.5B	5.2B	7.4B	8.5B	8.9B
Non Currrent Assets Other	(2.4B)	105.7M	124.9M	278.7M	320.5M	336.5M
Other Assets	36.9M	35.3M	239.4M	144.9M	166.6M	100.4M
Cash And Short Term Investments	2.5B	3.0B	3.4B	3.1B	3.6B	2.3B
Net Receivables	939.3M	1.5B	1.5B	1.6B	1.9B	1.1B
Short Term Investments	2.4B	2.4B	3.3B	278.7M	320.5M	304.5M
Liabilities And Stockholders Equity	6.6B	9.2B	11.5B	14.0B	16.1B	8.1B
Non Current Liabilities Total	182.7M	213.2M	263.2M	331.1M	380.7M	211.6M
Inventory	529.0M	881.3M	1.1B	1.3B	1.4B	752.3M
Other Current Assets	4.9M	317.9M	325.8M	573.9M	660.0M	692.9M
Other Stockholder Equity	43.0M	47.8M	12.4M	24.7M	28.4M	37.1M
Total Liab	1.2B	1.6B	1.4B	1.9B	2.2B	1.3B
Total Current Assets	4.0B	5.7B	6.3B	6.6B	7.6B	4.4B
Accumulated Other Comprehensive Income	43.0M	47.8M	55.6M	66.7M	60.0M	47.7M
Short Term Debt	10.4M	(6.2M)	2M	1.6M	1.4M	1.3M
Intangible Assets	2.7M	4.7M	6.0M	7.4M	8.5M	4.4M
Property Plant Equipment	1.3B	1.7B	2.4B	3.4B	3.9B	2.2B
Net Invested Capital	5.4B	7.7B	10.1B	12.0B	13.8B	7.6B
Net Working Capital	2.9B	4.4B	5.1B	5.0B	5.7B	3.8B
Property Plant And Equipment Gross	3.2B	4.4B	4.8B	6.9B	8.0B	4.8B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Clean Stock

Balance Sheet is a snapshot of the financial position of Clean Science at a specified time, usually calculated after every quarter, six months, or one year. Clean Science Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Clean Science and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Clean currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clean Ebitda vs Cost Of Revenue Analysis

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Cost Of Revenue

Clean Science fundamental ratios Correlations

Clean Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clean Science fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Clean Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Net Receivables
Non Current Liabilities Total	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets

Cash	- 1.0	Net Debt
Cash	- 0.73	Short Long Term Debt Total
Cash	- 0.52	Other Current Liab
Other Assets	- 0.46	Non Currrent Assets Other
Net Debt	- 0.42	Current Deferred Revenue
Short Term Investments	- 0.41	Non Currrent Assets Other